======= SLC22A3 ======= == Gene Information == * **Official Symbol**: SLC22A3 * **Official Name**: solute carrier family 22 member 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6581|6581]] * **UniProt**: [[https://www.uniprot.org/uniprot/O75751|O75751]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SLC22A3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SLC22A3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604842|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Mediates potential-dependent transport of a variety of organic cations. May play a significant role in the disposition of cationic neurotoxins and neurotransmitters in the brain. {ECO:0000269|PubMed:10196521, ECO:0000269|PubMed:10966924}. |MFS 1| |Sugar tr| |histamine uptake| |quaternary ammonium group transmembrane transporter activity| |dopamine:sodium symporter activity| |toxin transmembrane transporter activity| |organic cation transmembrane transporter activity| |dopamine uptake| |histamine transport| |catecholamine uptake| |dopamine transport| |quaternary ammonium group transport| |catecholamine transport| |azole transport| |monoamine transport| |regulation of appetite| |neurotransmitter uptake| |organic cation transport| |toxin transport| |ammonium transport| |drug transmembrane transport| |organic hydroxy compound transport| |drug transport| |neurotransmitter transport| |regulation of neurotransmitter levels| |response to nutrient levels| |response to extracellular stimulus| |import into cell| |cation transport| |response to drug| |transmembrane transport| |ion transport| |integral component of plasma membrane| |nitrogen compound transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp444|THZ531 0.225μM R08 exp444]]|-2.18| |[[:results:exp177|Apcin 25μM plus proTAME 2μM R04 exp177]]|-2.12| |[[:results:exp528|TGF-beta1 44ng/ml R08 exp528]]|-1.93| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|-1.92| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|-1.77| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|-1.76| |[[:results:exp165|RO-3306 3 to 4μM on day4 R04 exp165]]|-1.73| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15141 * **Expression level (log2 read counts)**: -4.27 {{:chemogenomics:nalm6 dist.png?nolink |}}